XERSNasdaq United States
Market cap
$1.369 B
$7.93 +7.75%
Close of 7 Aug 2026
Revenue
$291.8M
#2147 by revenue
Earnings
$554.0K
#2419 by earnings
Shares outstanding
182,320,306
Latest filing cover page
P/E ratio
2471.2
Cap ÷ net income
Where these numbers come from
Share counts and financials for Xeris Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.